Overview

A Study to Assess Efficacy and Safety of the Ketoprofen vs Diclofenac

Status:
Completed
Trial end date:
2020-09-01
Target enrollment:
0
Participant gender:
All
Summary
Primary objective: • To assess therapeutic efficacy of the Ketoprofen compared with Diclofenac based on the assessment of primary endpoint : Mean change in walking arthritis pain intensity score Secondary objectives: - To assess therapeutic efficacy of the Ketoprofen compared with Diclofenac based on the assessment of secondary endpoints. - To assess safety and tolerability of the Ketoprofen compared with Diclofenac based on the nature and frequency of adverse events in treatment groups
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Handok Inc.
Treatments:
Diclofenac
Ketoprofen
Criteria
Inclusion Criteria:

- Patients aged 40-75 years

- Compliance to ACR diagnostic criteria of OA of the knee

- Patients with Kellgren-Lawrence grade 1-3

- Index knee pain should be ≥40 mm on VAS (100mm) scale

Exclusion Criteria:

- Intolerance or allergic reactions to the study therapy

- Usage of NSAIDs within 3 days

- Open skin lesions or dermatological conditions at the site of plaster application

- Surgery or major trauma of the index knee within the previous 12 months

- Pregnant or breast-feeding women

- Alcohol addiction, drug addiction or drug abuse in the past